Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells.

Clinical laboratory - 1 Jun 2022

Jaddaoui Samiha, Bencharef Hanaa, Lamchahab Mouna, Quessar Asmaa, Oukkache Bouchra

Abstract excerpt

BACKGROUND: Leukemia stem cells (LSCs) have been demonstrated to be more therapy-resistant than leukemic blast cells reflecting measurable residual disease (MRD). CD34+CD38- cell frequency is an independent factor for relapse prediction and could therefore be used in the future to improve MRD assessment in acute myeloid leukemia (AML). This protocol is designed to enable accurate and reproducible immunophenotypic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-ribosyl Cyclase 1
Share to Antigens, CD34
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Flow Cytometry

Share to Hematopoietic Stem Cells

Share to Immunophenotyping

Share to Leukemia, Myeloid, Acute

Share to Neoplasm, Residual

Source

Identifiers

PMID: 35704721
DOI: 10.7754/Clin.Lab.2021.210821

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells.PMID 35704721Read ↗

CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.Semantic proximity Read ↗

Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid LeukemiaSemantic proximity Read ↗

[Prognostic Significance of the Percentage of Blasts with CD34+/CD38low/-/CD123+ Phenotype in Acute Myeloid Leukemias].Semantic proximity Read ↗

[Prognostic value of residual disease detection in acute myeloid leukemia with normal karyotype and negative FLT3-ITD].Semantic proximity Read ↗

LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells.Semantic proximity Read ↗

Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.Semantic proximity Read ↗

Leukemia‐associated immunophenotypes subdivided in “categories of specificity” improve the sensitivity of minimal residual disease in predicting relapse in acute myeloid leukemiaSemantic proximity Read ↗

Quantitative assessment of the CD26+ leukemic stem cell compartment in chronic myeloid leukemia: patient-subgroups, prognostic impact, and technical aspectsSemantic proximity Read ↗

Hematopoietic stem cells can be separated from leukemic cells in a subgroup of adult acute lymphoblastic leukemia patients.Semantic proximity Read ↗

Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.Semantic proximity Read ↗

Detection of molecular targets on the surface of CD34<sup>+</sup>CD38<sup>−</sup> bone marrow cells in myelodysplastic syndromesSemantic proximity Read ↗

Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.